Introduction
Age-period-cohort (APC) analysis could provide useful insight into the interpretation of time trends for disease rates. 1, 2 The age effect represents the differing risks associated with different age groups. The period effect represents a change in rate that is associated with all age groups simultaneously. The cohort effect is associated with a change in rates in successive age groups in successive time periods. The APC model has been used to analyze the time trends in epilepsy mortality in England and Wales and in the US between 1950 and 1994, and indicated pronounced cohort effects. 3 In the US, epilepsy mortality fell with each successive cohort after 1905, while in England and Wales, there was a similar decline in cohort mortality after 1905 for women, but this was not observed until after 1950 for men. In addition to the secular trend, there are geographic variations in epilepsy mortality rates across countries. 4 As indicated by a recent review, the epidemiology of epilepsy in Asian countries is underappreciated. 5 Most of the previous epilepsy mortality studies were performed in Western countries, and little is known about the experience in Asian countries. We therefore aimed in this study to use the APC model to examine the epilepsy mortality trends in Taiwan between 1971 and 2005 and to determine whether the patterns of age, period and cohort effects on epilepsy mortality in Taiwan were similar to those in the US and in England and Wales.
Materials and methods

Data sources
Mortality data for the years 1971 through 2005 were retrieved from Taiwan's National Mortality Registry, Department of Health. The population data were derived from the national annual household registration statistics published by the Ministry of the Interior of Taiwan. The International Classification of Diseases, Eighth and Ninth Revisions (ICD-8 and ICD-9) code 345 was used to identify deaths in which the underlying-cause-of-death was epilepsy.
Calculation of mortality rates
The mortality rate was calculated for fifteen 5-year age intervals (i.e., 0-4, 5-9, 10-14, . . ., 65-69 and 70-74 years old) and seven 5-year calendar periods (1971-75, 1976-80, 1981-85,1986 -90, Seizure 20 (2011) 
APC analysis
To solve the limitations of traditional statistical models in assessing the respective effects of age, period and cohort, we employed a three-phase method that conceptualizes the cohort effect as a partial interaction between age and period. 6, 7 The threephase method begins with graphical inspection; second, a median polish is used to remove the log-additive components of age and period effects; and third, a linear regression of residuals from the median polish is modeled to quantify the relative magnitude of the cohort effect. 7 According to Keyes and Li, 7 a general two-factor model for the rate (Y ij ) is that it is a function of vector (a i ), the ith of m À 1 age effects, and vector (b j ), the jth of n À 1 period effects. The natural log of Y ij is modeled as a constant term (m) plus a i , b j , and an error term (e ij ):
The error term represents the residual unaccounted for by the log-additive effects of age and period. Eq. (1) can be rewritten as:
where d ij denotes a multiplicative interaction between the age and period effects. Eq. (2) represents the saturated model of the ageperiod data; the error term in the model is equal to zero. The variance attributable to the multiplicative interaction term in the fully-saturated model is then partitioned into systematic and nonsystematic components. The systematic component is considered the cohort effect, and the remaining variance is considered random error. Thus, the cohort effect is a partial multiplicative interaction between age and period.
The effect of each parameter (i.e., age, period, and cohort) was indicated by the relative risk (RR) and 95% confidence intervals (95% CI), using the age interval of 35-39 years, the 1986-1990 calendar period, and the 1951-1955 cohort as references. The statistical significance of the epilepsy mortality rates by age, period, and cohort individually or collectively was tested using analyses of deviance for the regression model. All analyses were performed using SAS 8.0 (SAS Institute, Cary, NC). 8 
Results
During the study period, a total of 5226 deaths from epilepsy were identified from the dataset. The mortality rates were found to be higher in males than in females; however, the effects of age, period, and cohort were similar for both sexes, and we therefore have not presented the results by sex in the following sections. The secular trend in epilepsy mortality differed by age (Fig. 1) . The mortality rate for the elderly declined first from 1971-75 to 1981-85 and then increased consistently from 1981-85 to 2001-05. However, the mortality rates for children, adolescents and adults have not declined since 1991-95. Fig. 2 shows the cohort-specific mortality from epilepsy. We found that the later the cohort (especially 1961-80 and 1981-05), the lower the mortality rate.
The mortality rates for children and adolescents in the cohort of 1981-05 were lower than those in the cohort of 1961-80.
The effects of components of the APC model on epilepsy mortality are shown in Fig. 3 and Table 1 . We found profound effects of age on epilepsy mortality in Taiwan. The RR increased sharply during adolescence, leveled off during adulthood, and then increased steeply in the elderly. Using age group 35-39 year old as a reference, the RR was significantly lower than the reference for deceased aged 0-19 years and significantly higher for deceased aged 65 years and above.
The RR of period effects decreased from period 1971-1975 to period 1991-1995 and then increased from period 1991-1995 to period 2001-2005. However, the changes were not statistically significant. We did not find any significant cohort effects, with the exception of cohort 1911-1915, which had a significantly lower RR as compared with the reference cohort (i.e., 1951-1955).
Discussion
Main findings
Some of the findings (age effects) of APC model analysis in this study were similar to those of previous research, such as an increase in mortality risk during adolescence and old age. However, some of the findings (period and cohort effects) differ Age group (years) Mortality rate per million person-years from those of previous studies. We found a steeper increasing mortality trend among the elderly, no decline in the mortality rates for children, adolescents and adults, and no decrease in mortality risk in recent successive cohorts in Taiwan; these results were in contrast with those reported for England and Wales and for the US. 
Limitations of this study
Before we move to the interpretation of the findings of this study, we should first examine the limitations of this study. Several scholars have pointed out methodological issues in studies of mortality from epilepsy. [9] [10] [11] [12] [13] One of the limitations of this study was the use of official published mortality data instead of cohorts of patients with epilepsy. The official published mortality data are based on the underlying cause-of-death, which is defined as the disease or injury that initiated the train of morbid events. 14 Given the same epilepsy-related death (e.g., drowning while seizing, aspiration pneumonia during a seizure, etc.), epilepsy might be reported as the underlying cause-of-death by some certifying physicians and as a contributory cause-of-death by other certifying physicians, and we were unable to differentiate whether a death was directly or indirectly due to epilepsy. Another limitation in using official published mortality data was the underreporting of epilepsy on death certificates. According to the study of Bell et al., in only 7% of patients with epilepsy is epilepsy reported on the death certificate. In some patients with active epilepsy, epilepsy does not appear on the death certificate. 10 The reporting rate was estimated to be around 10% in Taiwan according to the study of Tsai. 12 Given the above limitations, caution should be taken in interpreting the epilepsy mortality trends.
Interpreting the findings
O'Callaghan et al. 3 suggested that the increase in mortality risk during adolescence might be due to poor compliance with antiepileptic treatment, as during this age period adolescents are moving away from parental supervision. The subsequent leveling-off in mortality during adulthood may reflect a more responsible approach that comes with increasing maturity. The increase in mortality risk from epilepsy among the elderly in Taiwan is compatible with the age pattern of the prevalence of treated epilepsy estimated according to the National Health Insurance dataset. 15 The prevalence of cerebrovascular disease increases with age, and it is well-known that cerebrovascular disease is an important risk factor of symptomatic epilepsy; therefore, we could expect a higher prevalence of epilepsy among the elderly, consequently resulting in a higher mortality from epilepsy. 16 Unlike the pattern of mortality trends (i.e., a prominent decrease for the deceased aged 69 years old and lower and a mild increase for the elderly aged 70 and above) in England and Wales and in the US, a steep increase in mortality rates among the elderly and no decline in mortality rates among children, adolescents and adults were found in Taiwan. Even worse, we found an increase in mortality risk in the periods 1996-2000 and 2001-2005 and cohort 1991-1995 according to APC analysis.
One possible explanation of the higher mortality from epilepsy in Taiwan is the poorer quality of treatment of patients with epilepsy in Taiwan as compared with England and Wales and the US. One hospital-based study in Taiwan suggested a higher fatality rate of patients with epilepsy as compared with similar hospitalbased studies in Japan and India. 17 In addition, a nationwide population-based study indicated that the antiepileptic drugs used in Taiwan were dominated by first-generation drugs and the mean dosages of most antiepileptic drugs were lower than those suggested by the World Health Organization. 1971-1975 1976-1980 1981-1985 1986-1990 1991-1995 1996-2000 2001-2005 1911-1915 1916-1920 1921-1925 1926-1930 1931-1935 1936-1940 1941-1945 1946-1950 1951-1955 1956-1960 1961-1965 1966-1970 1971-1975 1976-1980 1981-1985 1986-1990 1991-1995 Age Period Cohort Rate raƟo Fig. 3 . Adjusted epilepsy mortality rate ratios of age, period, and cohort effects according to age-period-cohort analysis in Taiwan, 1971-2005. financial barriers to accessing health care. 19 Evaluation studies have suggested that the NIH program is of most benefit to children, the elderly, and people living in the most deprived areas. 20, 21 It is highly possible that more patients with epilepsy receive regular treatment owing to the NHI program and therefore a diagnosis of ''epilepsy'' is more likely to be reported as a COD on the death certificate by certifying physicians. Another possible explanation is the improvement in COD reporting and the coding procedure since 2000. The Department of Health of Taiwan initiated a systematic evaluation of the quality of COD reporting by certifying physicians and the quality of the coding procedure in selecting the underlying COD in the late 1990s. 22, 23 The Department of Health then introduce ACME, software developed by the National Center for Health Statistics of the US, to standardize the procedure for selecting the underlying COD in the early 2000s. 24, 25 The increase in mortality rates might to some extent reflect better reporting and coding of epilepsyrelated deaths rather than a real increase in mortality risk. Further studies are needed to examine this hypothesis.
In conclusion, despite the limitations of using official published mortality data, we nevertheless found prominent age effects according to APC analysis, which were similar to the results of previous research. However, the patterns of the period and cohort effects on epilepsy mortality in Taiwan differed from those in England and Wales and in the US. Further studies are needed to examine the reasons for the lack of a decline in mortality in period 2001-2005 and the later cohorts in Taiwan.
